Peptide reactivity associated with skin sensitization: The QSAR Toolbox and TIMES compared to the DPRA

Toxicology in Vitro

Volumn 34, Issue , 2016, Pages 194-203

  Urbisch, D ^a   Honarvar, N ^a   Kolle, S N ^a   Mehling, A ^a   Ramirez, T ^a   Teubner, W ^b   Landsiedel, R ^a  

^a BASF SE   (Germany)

^b CIBA GEIGY LTD   (Switzerland)

Author keywords

Direct peptide reactivity assay (DPRA); In chemico; In silico; Protein binding; Quantitative structure activity relationship (QSAR); Skin sensitization

Indexed keywords

PEPTIDE; 1-PHENYL-1,2-PROPANEDIONE; 2-ACETYLCYCLOHEXANONE; ALKANONE; ALPHA-FURIL; BENZOYLACETONE; CHALCONE DERIVATIVE; CYCLOHEXANONE DERIVATIVE; FURAN DERIVATIVE; HAPTEN; METHYL PYRUVATE; PROTEIN BINDING; PYRUVIC ACID DERIVATIVE;

ARTICLE; ASSAY; AUTOOXIDATION; CHEMICAL ANALYSIS; COMPUTER MODEL; COMPUTER PREDICTION; CONTROLLED STUDY; DIRECT PEPTIDE REACTIVITY ASSAY; EXPERT SYSTEM; HUMAN CELL LINE ACTIVATION TEST; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; LOCAL LYMPH NODE ASSAY; LUCIFERASE ASSAY; LUSENS ASSAY; MEASUREMENT ACCURACY; PREDICTIVE VALUE; PROTEIN BINDING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SENSITIVITY AND SPECIFICITY; SKIN SENSITIZATION; SKIN TEST; TISSUE METABOLISM; TISSUE METABOLISM SIMULATOR FOR SKIN SENSITIZATION; ANIMAL; COMPUTER SIMULATION; HUMAN; METABOLISM; MOUSE; SKIN ALLERGY; THEORETICAL MODEL;

ANIMALS; BUTANONES; CHALCONES; COMPUTER SIMULATION; CYCLOHEXANONES; DERMATITIS, ALLERGIC CONTACT; FURANS; HAPTENS; HUMANS; LOCAL LYMPH NODE ASSAY; MICE; MODELS, THEORETICAL; PEPTIDES; PROTEIN BINDING; PYRUVATES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84964334225     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2016.04.005     Document Type: Article

References (49)

1. Ahlfors S.R., Sterner O., Hansson C. Reactivity of contact allergenic haptens to amino acid residues in a model carrier peptide, and characterization of formed peptide-hapten adducts. Skin Pharmacol. Physiol. 2003, 16:59-68.
2. Aptula A.O., Roberts D.W. Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: general principles and application to reactive toxicity. Chem. Res. Toxicol. 2006, 19:1097-1105.
3. Ashikaga T., Yoshida Y., Hirota M., Yoneyama K., Itagaki H., Sakaguchi H., Miyazawa M., Ito Y., Suzuki H., Toyoda H. Development of an in vitro skin sensitization test using human cell lines: the human cell line activation test (h-CLAT) I. Optimization of the h-CLAT protocol. Toxicol. in Vitro 2006, 20:767-773.
4. Basketter D., Ashikaga T., Casati S., Hubesch B., Jaworska J., de K.J., Landsiedel R., Manou I., Mehling A., Petersohn D., Rorije E., Rossi L H., Steiling W., Teissier S., Worth A. Alternatives for skin sensitisation: hazard identification and potency categorisation: report from an EPAA/CEFIC LRI/Cosmetics Europe cross sector workshop, ECHA Helsinki, April 23rd and 24th 2015. Regul. Toxicol. Pharmacol. 2015, 73:660-666.
5. Bauch C., Kolle S.N., Ramirez T., Eltze T., Fabian E., Mehling A., Teubner W., van Ravenzwaay B., Landsiedel R. Putting the parts together: combining in vitro methods to test for skin sensitizing potentials. Regul. Toxicol. Pharmacol. 2012, 63:489-504.
6. Cooper J.A., Saracci R., Cole P. Describing the validity of carcinogen screening-tests. Br. J. Cancer 1979, 39:87-89.
7. Dimitrov S.D., Low L.K., Patlewicz G.Y., Kern P.S., Dimitrova G.D., Comber M.H.I., Phillips R.D., Niemela J., Bailey P.T., Mekenyan O.G. Skin sensitization: modeling based on skin metabolism simulation and formation of protein conjugates. Int. J. Toxicol. 2005, 24:189-204.
8. Dupuis G., Benezra C. Allergic Contact Dermatitis to Simple Chemicals: A Molecular Approach 1982, 200pp, Marcel Dekker, New York, NY, USA & Basel, Switzerland.
9. Emter R., Ellis G., Natsch A. Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro. Toxicol. Appl. Pharmacol. 2010, 245:281-290.
10. Enoch S.J., Roberts D.W., Cronin M.T. Electrophilic reaction chemistry of low molecular weight respiratory sensitizers. Chem. Res. Toxicol. 2009, 22:1447-1453.
11. EURL-ECVAM EURL ECVAM Recommendation on the Human Cell Line Activation Test (H-CLAT) for Skin Sensitisation Testing 2015.
12. Gerberick F.M., Basketter D., Casati S., Karlberg A T., Kern P., Kimber I., Lepoittevin J P., Natsch A., Ovigne J M., Rovida C., Sakaguchi H., Schultz T. Chemical Reactivity Measurement and the Predictive Identification of Skin Sensitisers. Atla-Alternatives to Laboratory Animals 2008, Vol. 36:215-242.
13. Gerberick G.F., Troutman J.A., Foertsch L.M., Vassallo J.D., Quijano M., Dobson R.L.M., Goebel C., Lepoittevin J.P. Investigation of peptide reactivity of pro-hapten skin sensitizers using a peroxidase-peroxide oxidation system. Toxicol. Sci. 2009, 112:164-174.
14. Gerberick G.F., Vassallo J.D., Bailey R.E., Chaney J.G., Morrall S.W., Lepoittevin J.P. Development of a peptide reactivity assay for screening contact allergens. Toxicol. Sci. 2004, 81:332-343.
15. Gerberick G.F., Vassallo J.D., Foertsch L.M., Price B.B., Chaney J.G., Lepoittevin J.P. Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. Toxicol. Sci. 2007, 97:417-427.
16. Hirota M., Fukui S., Okamoto K., Kurotani S., Imai N., Fujishiro M., Kyotani D., Kato Y., Kasahara T., Fujita M., Toyoda A., Sekiya D., Watanabe S., Seto H., Takenouchi O., Ashikaga T., Miyazawa M. Evaluation of combinations of in vitro sensitization test descriptors for the artificial neural network-based risk assessment model of skin sensitization. J. Appl. Toxicol. 2015, 35:1333-1347.
17. Matheson J. ICCVAM integrated decision strategy for skin sensitization http://ntp.niehs.nih.gov/iccvam/meetings/sot15/matheson-poster-text-508.pdf.
18. Jaworska J.S., Natsch A., Ryan C., Strickland J., Ashikaga T., Miyazawa M. Bayesian integrated testing strategy (ITS) for skin sensitization potency assessment: a decision support system for quantitative weight of evidence and adaptive testing strategy. Arch. Toxicol. 2015, 89:2355-2383.
19. Joint Cefic LRI/Cosmetics Europe/EPAA workshop HHA2 http://cefic-lri.org/events/joint-cross-sector-workshop-on-alternatives-for-skin-sensitization-testing-and-assessment/.
20. Landsteiner K., Jacobs J. Studies on the sensitization of animals with simple chemical compounds. J. Exp. Med. 1936, 64:625-639.
21. Lepoittevin J., Basketter D.A., Goossens A., Karlberg A.T. Allergic contact dermatits: The molecular basis 1998, Springer, Berlin.
22. Lepoittevin J.P. Metabolism versus chemical transformation or pro- versus prehaptens?. Contact Dermatitis 2006, 54:73-74.
23. Lepoittevin J., Benezra C. C-13-enriched methyl alkanesulfonates - new lipophilic methylating agents for the identification of nucleophilic amino acids of proteins by NMR. Tetrahedron Lett. 1992, 33:3875-3878.
24. Macmillan D.S., Canipa S.J., Chilton M.L., Williams R.V., Barber C.G. Predicting skin sensitisation using a decision tree integrated testing strategy with an in silico model and in chemico/in vitro assays. Regul. Toxicol. Pharmacol. 2016, 76:30-38.
25. Natsch A., Emter R., Gfeller H., Haupt T., Ellis G. Predicting skin sensitizer potency based on in vitro data from KeratinoSens and kinetic peptide binding: global versus domain-based assessment. Toxicol. Sci. 2015, 143:319-332.
26. Natsch A., Gfeller H. LC-MS-based characterization of the peptide reactivity of chemicals to improve the in vitro prediction of the skin sensitization potential. Toxicol. Sci. 2008, 106:464-478.
27. Natsch A., Gfeller H., Haupt T., Brunner G. Chemical reactivity and skin sensitization potential for benzaldehydes: can Schiff base formation explain everything?. Regul. Toxicol. Pharmacol. 2012, 25:2203-2215.
28. Natsch A., Gfeller H., Rothaupt M., Ellis G. Utility and limitations of a peptide reactivity assay to predict fragrance allergens in vitro. Toxicol. in Vitro 2007, 21:1220-1226.
29. Natsch A., Ryan C.A., Foertsch L., Emter R., Jaworska J., Gerberick F., Kern P. A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation. J. Appl. Toxicol. 2013, 33:1337-1352.
30. OECD The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins. Part 1: Scientific Evidence 2012.
31. OECD The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins. Part 2: Use of the AOP to Develop Chemical Categories and Integrated Assessment and Testing Approaches 2012.
32. OECD OECD TG 442C: In chemico Skin Sensitization: Direct Peptide Reactivity Assay (DPRA) 2015.
33. OECD OECD TG 442D: In Vitro Skin Sensitization: ARE-Nrf2 Luciferase Test Methods 2015.
34. Patlewicz G., Dimitrov S.D., Low L.K., Kern P.S., Dimitrova G.D., Comber M.I., Aptula A.O., Phillips R.D., Niemela J., Madsen C., Wedebye E.B., Roberts D.W., Bailey P.T., Mekenyan O.G. TIMES-SS - a promising tool for the assessment of skin sensitization hazard. A characterization with respect to the OECD validation principles for (Q)SARs and an external evaluation for predictivity. Regul. Toxicol. Pharmacol. 2007, 48:225-239.
35. Patlewicz G., Kuseva C., Kesova A., Popova I., Zhechev T., Pavlov T., Roberts D.W., Mekenyan O. Towards AOP application-implementation of an integrated approach to testing and assessment (IATA) into a pipeline tool for skin sensitization. Regul. Toxicol. Pharmacol. 2014, 69:529-545.
36. Patlewicz G., Kuseva C., Mehmed A., Popova Y., Dimitrova G., Ellis G., Hunziker R., Kern P., Low L., Ringeissen S., Roberts D.W., Mekenyan O. TIMES-SS-recent refinements resulting from an industrial skin sensitisation consortium. SAR QSAR. Environ. Res. 2014, 25:367-391.
37. Ramirez T., Mehling A., Kolle S.N., Wruck C.J., Teubner W., Eltze T., Aumann A., Urbisch D., van R.B., Landsiedel R. LuSens: a keratinocyte based ARE reporter gene assay for use in integrated testing strategies for skin sensitization hazard identification. Toxicol. in Vitro 2014, 28:1482-1497.
38. Raunio H. In silico toxicology - non-testing methods. Front. Pharmacol. 2011, 2:33.
39. Roberts D.W., Aptula A.O., Patlewicz G. Mechanistic applicability domains for non-animal based prediction of toxicological endpoints. QSAR analysis of the Schiff base applicability domain for skin sensitization. Chem. Res. Toxicol. 2006, 19:1228-1233.
40. Roberts D.W., Natsch A. High throughput kinetic profiling approach for covalent binding to peptides: application to skin sensitization potency of Michael acceptor electrophiles. Chem. Res. Toxicol. 2009, 22:592-603.
41. Roberts D.W., Patlewicz G., Kern P.S., Gerberick F., Kimber I., Dearman R.J., Ryan C.A., Basketter D.A., Aptula A.O. Mechanistic applicability domain classification of a local lymph node assay dataset for skin sensitization. Chem. Res. Toxicol. 2007, 20:1019-1030.
42. Romagnoli P., Labhardt A.M., Sinigaglia F. Selective interaction of Ni with an MHC-bound peptide. EMBO J. 1991, 10:1303-1306.
43. Teissier Silvia, Alépée Nathalie Case study 5: L'OREAL approach & decision strategy http://cefic-lri.org/wp-content/uploads/2014/03/G-Case-Study-3-LOreal-April-2015.pdf.
44. Takenouchi O., Fukui S., Okamoto K., Kurotani S., Imai N., Fujishiro M., Kyotani D., Kato Y., Kasahara T., Fujita M., Toyoda A., Sekiya D., Watanabe S., Seto H., Hirota M., Ashikaga T., Miyazawa M. Test battery with the human cell line activation test, direct peptide reactivity assay and DEREK based on a 139 chemical data set for predicting skin sensitizing potential and potency of chemicals. J. Appl. Toxicol. 2015, 35:1318-1332.
45. Teubner W., Mehling A., Schuster P.X., Guth K., Worth A., Burton J., van R.B., Landsiedel R. Computer models versus reality: how well do in silico models currently predict the sensitization potential of a substance. Regul. Toxicol. Pharmacol. 2013, 67:468-485.
46. Troutman J.A., Foertsch L., Kern P.S., Dai H.J., Quijano M., Dobson R.L.M., Lalko J.F., Lepoittevin J.P., Gerberick G.F. The incorporation of lysine into the peroxide-peptide reactivity assay for skin sensitization assessment. Toxicol. Sci. 2011, 122:422-436.
47. Urbisch D., Mehling A., Guth K., Ramirez T., Honarvar N., Kolle S., Landsiedel R., Jaworska J., Kern P.S., Gerberick F., Natsch A., Emter R., Ashikaga T., Miyazawa M., Sakaguchi H. Assessing skin sensitization hazard in mice and men using non-animal test methods. Regul. Toxicol. Pharmacol. 2015, 71:337-351.
48. Urbisch D., Becker M., Honarvar N., Kolle S.N., Mehling A., Teubner W., Wareing B., Landsiedel R. Assessment of pre- and pro-haptens using non-animal test methods for skin sensitization. Chem. Res. Toxicol. 2016, (submitted).
49. van der Veen J.W., Rorije E., Emter R., Natsch A., van L H., Ezendam J. Evaluating the performance of integrated approaches for hazard identification of skin sensitizing chemicals. Regul. Toxicol. Pharmacol. 2014, 69:371-379.